These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29382218)

  • 1. Motor neuron disease mortality rates in New Zealand 1992-2013.
    Cao MC; Chancellor A; Charleston A; Dragunow M; Scotter EL
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):285-293. PubMed ID: 29382218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor neuron disease mortality and lifetime petrol lead exposure: Evidence from national age-specific and state-level age-standardized death rates in Australia.
    Zahran S; Laidlaw MA; Rowe DB; Ball AS; Mielke HW
    Environ Res; 2017 Feb; 153():181-190. PubMed ID: 27992849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease.
    Chancellor AM; Swingler RJ; Fraser H; Clarke JA; Warlow CP
    J Epidemiol Community Health; 1993 Apr; 47(2):116-20. PubMed ID: 8326268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of amyotrophic lateral sclerosis.
    Kurtzke JF
    Adv Neurol; 1982; 36():281-302. PubMed ID: 6983824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor neuron disease and multiple sclerosis mortality in Australia, New Zealand and South Africa compared with England and Wales.
    Dean G; Elian M
    J Neurol Neurosurg Psychiatry; 1993 Jun; 56(6):633-7. PubMed ID: 8509776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increase in mortality for motor neuron disease in Italy, 1980-1999].
    Altavista P; Belli S; Binazzi A; Comba P; Mastrantonio M; Uccelli R; Vanacore N
    Epidemiol Prev; 2006; 30(2):108-13. PubMed ID: 16909959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999-2009.
    Mehal JM; Holman RC; Schonberger LB; Sejvar JJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):346-52. PubMed ID: 23621426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of motor neurone disease within MidCentral Region, New Zealand.
    Caulfield A; Cariga P
    N Z Med J; 2018 Nov; 131(1485):48-51. PubMed ID: 30408817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in motor neuron disease: association with latitude and air lead levels in Spain.
    Santurtún A; Villar A; Delgado-Alvarado M; Riancho J
    Neurol Sci; 2016 Aug; 37(8):1271-5. PubMed ID: 27098242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological characteristics of motor neuron disease in Chinese patients.
    Cui F; Liu M; Chen Y; Huang X; Cui L; Fan D; Pu C; Lu J; Zhou D; Zhang C; Yan C; Li C; Ding X; Liu Y; Li X; Jiang Y; Zhang J; Shang H; Yao X; Ding Y; Niu Q; Wang L
    Acta Neurol Scand; 2014 Aug; 130(2):111-7. PubMed ID: 24689740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
    Conde B; Winck JC; Azevedo LF
    Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in motor neuron disease mortality in Spain: temporal and geographical analysis (1990-2005).
    Alonso V; Villaverde-Hueso A; Hens MJ; Morales-Piga A; Abaitua I; de la Paz MP
    Amyotroph Lateral Scler; 2011 May; 12(3):192-8. PubMed ID: 21198417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential features of motor neuron disease mortality in Spain.
    Veiga-Cabo J; Almazán-Isla J; Sendra-Gutiérrez JM; de Pedro-Cuesta J
    Int J Epidemiol; 1997 Oct; 26(5):1024-32. PubMed ID: 9363524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nationwide incidence of motor neuron disease using the French health insurance information system database.
    Kab S; Moisan F; Preux PM; Marin B; Elbaz A
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):426-433. PubMed ID: 28387141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture.
    Fong KY; Yu YL; Chan YW; Kay R; Chan J; Yang Z; Kwan MC; Leung KP; Li PC; Lam TH; Cheung RT
    Neuroepidemiology; 1996; 15(5):239-45. PubMed ID: 8878076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of motor neuron diseases in a Mexico City referral center.
    Otero-Siliceo E; Arriada-Mendicoa N; Corona-Vázquez T
    Rev Invest Clin; 1997; 49(6):445-8. PubMed ID: 9528303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Temporal Association between Accumulated Petrol (Gasoline) Lead Emissions and Motor Neuron Disease in Australia.
    Laidlaw MA; Rowe DB; Ball AS; Mielke HW
    Int J Environ Res Public Health; 2015 Dec; 12(12):16124-35. PubMed ID: 26703636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyotrophic Lateral Sclerosis Mortality in the United States, 2011-2014.
    Larson TC; Kaye W; Mehta P; Horton DK
    Neuroepidemiology; 2018; 51(1-2):96-103. PubMed ID: 29990963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An all-Ireland epidemiological study of MND, 2004-2005.
    Donaghy C; O'Toole O; Sheehan C; Kee F; Hardiman O; Patterson V
    Eur J Neurol; 2009 Jan; 16(1):148-53. PubMed ID: 19087159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Record linkage between hospital discharges and mortality registries for motor neuron disease case ascertainment for the Spanish National Rare Diseases Registry.
    Ruiz E; Ramalle-Gómara E; Quiñones C;
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):275-8. PubMed ID: 24641576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.